• Sinovac Biotech filed a Form 6-K to correct a typographical error in Note 2 of its annual report on Form 20-F for fiscal year ended Dec. 31, 2024, originally filed April 30, 2026.
• Sub-numbering on pages F-13 and F-14 was incorrectly shown as “1” through “10” instead of “A” through “J,” matching references in related tables elsewhere in Note 2.
• No changes were made to financial statements or other disclosures, with report continuing to speak as of initial filing date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinovac Biotech Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-053039), on May 07, 2026, and is solely responsible for the information contained therein.